Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan
· Delayed Price · Currency is JPY 4,610.00
+30.00 (0.66%)
Mar 10, 2026, 12:44 PM JST
Kissei Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 15,610 | 14,449 | 13,680 | 16,507 | 7,476 | Upgrade
|
| Depreciation & Amortization | - | 4,615 | 4,254 | 4,109 | 3,730 | 3,148 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 3,110 | -80 | -63 | 35 | 10 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -11,999 | -9,119 | -13,133 | -16,161 | -4,727 | Upgrade
|
| Other Operating Activities | - | -4,427 | -1,893 | -5,799 | -2,672 | -769 | Upgrade
|
| Change in Accounts Receivable | - | -974 | -5,863 | 27 | 250 | -3,595 | Upgrade
|
| Change in Inventory | - | 1,316 | -3,480 | -3,810 | 1,130 | -6,679 | Upgrade
|
| Change in Accounts Payable | - | -291 | 275 | 513 | -3,804 | 2,671 | Upgrade
|
| Change in Other Net Operating Assets | - | -439 | -220 | -2,203 | 2,518 | -77 | Upgrade
|
| Operating Cash Flow | - | 6,521 | -1,677 | -6,679 | 1,533 | -2,542 | Upgrade
|
| Capital Expenditures | - | -4,507 | -1,201 | -2,103 | -1,489 | -931 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 519 | 175 | 78 | 23 | 3 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -523 | -632 | -444 | -430 | -554 | Upgrade
|
| Investment in Securities | - | 13,091 | 9,502 | 13,031 | 16,391 | 790 | Upgrade
|
| Other Investing Activities | - | -3,627 | 844 | -4,564 | -3,741 | -8,669 | Upgrade
|
| Investing Cash Flow | - | 4,952 | 8,690 | 6,001 | 10,776 | -9,329 | Upgrade
|
| Short-Term Debt Issued | - | 170 | - | - | - | - | Upgrade
|
| Total Debt Issued | - | 170 | - | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -230 | -150 | -150 | -90 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -13 | -16 | Upgrade
|
| Total Debt Repaid | - | -230 | -150 | -150 | -103 | -16 | Upgrade
|
| Net Debt Issued (Repaid) | - | -60 | -150 | -150 | -103 | -16 | Upgrade
|
| Repurchase of Common Stock | - | -5,293 | -6,000 | - | - | -1,303 | Upgrade
|
| Common Dividends Paid | - | -3,801 | -3,722 | -3,135 | -2,536 | -2,475 | Upgrade
|
| Other Financing Activities | - | -171 | -134 | -135 | -117 | -206 | Upgrade
|
| Financing Cash Flow | - | -9,325 | -10,006 | -3,420 | -2,756 | -4,000 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 27 | -3 | -21 | 4 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 96 | -1 | -1 | - | -1 | Upgrade
|
| Net Cash Flow | - | 2,271 | -2,997 | -4,120 | 9,557 | -15,872 | Upgrade
|
| Free Cash Flow | - | 2,014 | -2,878 | -8,782 | 44 | -3,473 | Upgrade
|
| Free Cash Flow Margin | - | 2.28% | -3.81% | -13.01% | 0.07% | -5.03% | Upgrade
|
| Free Cash Flow Per Share | - | 46.17 | -63.59 | -190.44 | 0.95 | -74.42 | Upgrade
|
| Cash Interest Paid | - | 22 | 18 | 20 | 23 | 23 | Upgrade
|
| Cash Income Tax Paid | - | 4,357 | 1,834 | 5,699 | 2,567 | 652 | Upgrade
|
| Levered Free Cash Flow | - | 2,448 | 200.38 | -7,654 | 3,843 | -7,691 | Upgrade
|
| Unlevered Free Cash Flow | - | 2,461 | 211.63 | -7,641 | 3,858 | -7,677 | Upgrade
|
| Change in Working Capital | - | -388 | -9,288 | -5,473 | 94 | -7,680 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.